Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695862 | PMC |
http://dx.doi.org/10.3389/fimmu.2024.1529014 | DOI Listing |
ERJ Open Res
January 2025
Department of Otolaryngology-Head and Neck Surgery, University of California, Los Angeles, Los Angeles, CA, USA.
Background: Chronic rhinosinusitis (CRS) and olfactory dysfunction (OD) are prevalent disease complications in people with cystic fibrosis. These understudied comorbidities significantly impact quality of life. The impact of highly effective modulator therapy (HEMT) in young children with cystic fibrosis (YCwCF) on these disease complications is unknown.
View Article and Find Full Text PDFCardiovasc Diagn Ther
December 2024
Department of Congenital Heart Disease and Pediatric Cardiology, German Heart Center Munich, Technical University of Munich, Munich, Germany.
Background: Patients with congenital heart defects (CHDs) are at higher risk for infectious diseases. This may partly be due to frequent hospital stays and the associated exposure to pathogens. This study aims to provide a comprehensive overview of immunisation coverage among twins in which at least one twin has CHD.
View Article and Find Full Text PDFFront Immunol
December 2024
Department of Infectious Diseases, University of Georgia, Athens, GA, United States.
Pediatrics
December 2024
Sections of Pediatric Infectious Diseases/Epidemiology and General Academic Pediatrics, Department of Pediatrics, University of Colorado School of Medicine/Children's Hospital Colorado, Aurora, Colorado; and Adult and Child Center for Outcomes Research and Delivery Science, Aurora, Colorado.
Front Public Health
October 2024
Instituto de Efectividad Clínica y Sanitaria (IECS-CONICET), Buenos Aires, Argentina.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!